Using advanced imaging technology to develop new treatments for diseases
MicroSPECT/CT to aid the development of theranostics
This study is using a new advanced scanner to help researchers better understand diseases and develop new treatments, especially for infections and immune-related conditions, which could eventually lead to better options for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Case Western Reserve University NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-10852342 on NIH RePORTER |
What this research studies
This research involves the acquisition of a new preclinical SPECT-CT scanner at Case Western Reserve University to enhance imaging capabilities for various disease models. The scanner will support a wide range of research, including the development of novel theranostic agents and therapeutic strategies, particularly in the fields of anti-viral therapy and immunotherapy. By enabling detailed imaging of larger animals and infectious disease models, this project aims to facilitate significant advancements in basic science research and therapeutic development. Patients may benefit indirectly through the development of new treatments and therapies that arise from this research.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include those with conditions that are being targeted by the novel therapies developed through this imaging technology.
Not a fit: Patients with conditions unrelated to the diseases being studied or those who do not meet the criteria for the specific therapeutic developments may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of innovative treatments for various diseases, improving patient outcomes.
How similar studies have performed: Other research has shown success with similar imaging technologies in advancing therapeutic development, indicating a promising potential for this approach.
Where this research is happening
Cleveland, United States
- Case Western Reserve University — Cleveland, United States (Active)
Researchers
- Principal investigator: Lee, Zhenghong — Case Western Reserve University
- Study coordinator: Lee, Zhenghong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.